We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Groundbreaking AI Technology Accurately Diagnoses COVID-19 Using Chest X-Rays in Minutes

By HospiMedica International staff writers
Posted on 20 Jan 2022

A pioneering artificial intelligence (AI) technology is capable of accurately diagnosing COVID-19 in just a few minutes. More...

The groundbreaking program developed by researchers at University of the West of Scotland (UWS; Scotland, UK) is able to detect the virus far more quickly than a PCR test; which typically takes around two -hours. It is hoped that the technology can eventually be used to help relieve strain on hard-pressed accident and emergency departments, particularly in countries where PCR tests are not readily available.

The state-of-the-art technique utilizes X-ray technology, comparing scans to a database of around 3,000 images, belonging to patients with COVID-19, healthy individuals and people with viral pneumonia. It then uses an AI process known as deep convolutional neural network, an algorithm typically used to analyze visual imagery, to make a diagnosis. During an extensive testing phase, the technique proved to be more than 98% accurate. The team now plans to expand the study, incorporating a greater database of x-ray images acquired by different models of X-ray machines, to evaluate the suitability of the approach in a clinical setting.

“There has long been a need for a quick and reliable tool that can detect Covid-19, and this has become even more true with the upswing of the Omicron variant,” said Professor Naeem Ramzan, Director of the Affective and Human Computing for SMART Environments Research Centre at UWS, who led the team behind the project. “Several countries are unable to carry out large numbers of COVID tests because of limited diagnosis tools, but this technique utilizes easily accessible technology to quickly detect the virus.”

“COVID-19 symptoms are not visible in X-rays during the early stages of infection, so it is important to note that the technology cannot fully replace PCR tests. However, it can still play an important role in curtailing the viruses spread especially when PCR tests are not readily available. It could prove to be crucial, and potentially life-saving, when diagnosing severe cases of the virus, helping determine what treatment may be required,” added Professor Ramzan.

Related Links:
University of the West of Scotland


Gold Member
12-Channel ECG
CM1200B
Gold Member
Blood Gas Analyzer
i-Check200
Resorbable Bovine Collagen Membrane
GenDerm
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.